Efficacy of infliximab biosimilars in patients with Crohn's disease - Authors' reply
- PMID: 29208304
- DOI: 10.1016/S0140-6736(17)32463-7
Efficacy of infliximab biosimilars in patients with Crohn's disease - Authors' reply
Comment on
-
Efficacy of infliximab biosimilars in patients with Crohn's disease.Lancet. 2017 Dec 2;390(10111):2435. doi: 10.1016/S0140-6736(17)32459-5. Epub 2017 Dec 1. Lancet. 2017. PMID: 29208302 No abstract available.
-
Efficacy of infliximab biosimilars in patients with Crohn's disease.Lancet. 2017 Dec 2;390(10111):2435-2436. doi: 10.1016/S0140-6736(17)33047-7. Epub 2017 Dec 1. Lancet. 2017. PMID: 29208303 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical